HuGE Literature Finder
Records 1-6
|
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.
Cancer research and treatment : official journal of Korean Cancer Association 2020 Jul . Kim Se Ik, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sa |
|
Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.
Japanese journal of clinical oncology 2018 Jul . Sakurada Shoko, Watanabe Yoh, Tokunaga Hideki, Takahashi Fumiaki, Yamada Hidekazu, Takehara Kazuhiro, Yaegashi Nob |
|
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
Familial cancer 2013 Dec 12 (4): 719-40. Casey Murray Joseph, Bewtra Chhanda, Lynch Henry T, Snyder Carrie, Stacy Mark, Watson Patri |
|
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
Gynecologic oncology 2010 Sep 118 (3): 299-302. Vicus Danielle, Finch Amy, Cass Ilana, Rosen Barry, Murphy Joan, Fan Isabel, Royer Robert, McLaughlin John, Karlan Beth, Narod Steven |
|
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
Gynecologic oncology 2010 Aug 118 (2): 155-9. Vicus Danielle, Finch Amy, Rosen Barry, Fan Isabel, Bradley Linda, Cass Ilana, Sun Ping, Karlan Beth, McLaughlin John, Narod Steven A, |
|
High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 14 (22): 7569-73. Maehle Lovise, Apold Jaran, Paulsen Torbjørn, Hagen Bjørn, Løvslett Kjell, Fiane Bent, Van Ghelue Marijke, Clark Neal, Møller P |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: